|4Apr 17, 4:33 PM ET

Townsend John 4

4 · Unicycive Therapeutics, Inc. · Filed Apr 17, 2024

Insider Transaction Report

Form 4
Period: 2024-04-15
Townsend John
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2024-04-15+228,119875,309 total
    Exercise: $1.14Exp: 2034-04-15Common Stock (228,119 underlying)
Footnotes (1)
  • [F1]57,030 of the stock options vest on the first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.

Documents

1 file
  • 4
    ownership.xmlPrimary